Plasmatrix biotech Inc.

Zulma Guillot founder of Plasmatrix Biotech, currently in premanufacturing stage- Recognized for the development of advanced diagnostic/microfluidic platforms at the intersection of precision medicine. Our company has engineered to deliver laboratory-grade accuracy and precision through a rapid, automated multiplex cartridge system supported by advanced microfluidic technology at point of care transforming unmet clinical needs into commercially viable healthcare solutions. Beyond company building Im active in healthcare dialogue and innovation forums with UN for NYSDG, followed by public C3 International materials for “C3 Davos of Healthcare” having me within their Board of Advisors and Scientific Committee. My mission is to redefine how specialty diagnostics reach patients by bringing high-performance testing closer to where care happens